Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.3 GBX | +4.29% | +10.61% | +13.18% |
Apr. 18 | FTSE 100 up despite hawkish Fed rates outlook | AN |
Apr. 18 | AIM WINNERS & LOSERS: Surgical Innovations up as revenue jumps | AN |
Valuation
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 61.69 | 78.5 | 414.9 | 377.3 | 213.6 | 217.8 | - | - |
Enterprise Value (EV) 1 | 61.69 | 78.5 | 414.9 | 369.8 | 214.8 | 208.8 | 206.8 | 185.8 |
P/E ratio | 6.93 x | - | 10.4 x | 20.3 x | 16.6 x | 37.1 x | 9.13 x | 6.03 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | 1.43 x | - | 2.69 x | 1.5 x | 1.34 x | 1.02 x | 0.83 x |
EV / Revenue | - | 1.43 x | - | 2.64 x | 1.51 x | 1.29 x | 0.97 x | 0.71 x |
EV / EBITDA | - | - | - | 10.1 x | 8.66 x | 9.65 x | 5.24 x | 3.09 x |
EV / FCF | - | - | - | -67.9 x | -77.4 x | -11.9 x | 51.7 x | 13.8 x |
FCF Yield | - | - | - | -1.47% | -1.29% | -8.38% | 1.93% | 7.27% |
Price to Book | - | - | - | 1.85 x | 1.06 x | 1.04 x | 1.04 x | 0.91 x |
Nbr of stocks (in thousands) | 1,855,301 | 2,136,187 | 2,242,509 | 2,657,051 | 2,738,130 | 2,983,494 | - | - |
Reference price 2 | 0.0332 | 0.0368 | 0.1850 | 0.1420 | 0.0780 | 0.0730 | 0.0730 | 0.0730 |
Announcement Date | 11/14/19 | 11/10/20 | 12/2/21 | 10/25/22 | 10/11/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 54.77 | - | 140 | 142 | 162.4 | 212.5 | 262.9 |
EBITDA 1 | - | - | - | 36.77 | 24.8 | 21.63 | 39.47 | 60.2 |
EBIT 1 | - | 15.89 | - | 25.64 | 15.52 | 6 | 26.5 | 46.4 |
Operating Margin | - | 29.01% | - | 18.32% | 10.93% | 3.69% | 12.47% | 17.65% |
Earnings before Tax (EBT) 1 | - | - | - | 26.51 | 12.28 | 15.4 | 26.77 | 52.43 |
Net income 1 | 6.994 | - | 39.6 | 18.04 | 12.91 | 5 | 17 | 35.87 |
Net margin | - | - | - | 12.88% | 9.09% | 3.08% | 8% | 13.64% |
EPS 2 | 0.004800 | - | 0.0178 | 0.007000 | 0.004700 | 0.001970 | 0.008000 | 0.0121 |
Free Cash Flow 1 | - | - | - | -5.447 | -2.776 | -17.5 | 4 | 13.5 |
FCF margin | - | - | - | -3.89% | -1.95% | -10.77% | 1.88% | 5.14% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 10.14% | 22.43% |
FCF Conversion (Net income) | - | - | - | - | - | - | 23.53% | 37.64% |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 11/14/19 | 11/10/20 | 12/2/21 | 10/25/22 | 10/11/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2024 S1 |
---|---|
Net sales | - |
EBITDA 1 | 11.7 |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income | - |
Net margin | - |
EPS 2 | 0.001600 |
Dividend per Share | - |
Announcement Date | 2/26/24 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 1.24 | - | - | - |
Net Cash position 1 | - | - | - | 7.55 | - | 9 | 11 | 32 |
Leverage (Debt/EBITDA) | - | - | - | - | 0.0499 x | - | - | - |
Free Cash Flow 1 | - | - | - | -5.45 | -2.78 | -17.5 | 4 | 13.5 |
ROE (net income / shareholders' equity) | - | - | - | - | 6.37% | 3% | 10% | 15% |
ROA (Net income/ Total Assets) | - | - | - | 7.39% | 4.35% | 2% | 5% | 10% |
Assets 1 | - | - | - | 244.1 | 296.9 | 250 | 340 | 358.7 |
Book Value Per Share 2 | - | - | - | 0.0800 | 0.0700 | 0.0700 | 0.0700 | 0.0800 |
Cash Flow per Share 2 | - | - | - | 0.0100 | 0.0100 | - | 0.0100 | 0.0100 |
Capex 1 | - | - | - | 36.5 | 33.8 | 21.5 | 22 | 15 |
Capex / Sales | - | - | - | 26.04% | 23.79% | 13.24% | 10.35% | 5.71% |
Announcement Date | 11/14/19 | 11/10/20 | 12/2/21 | 10/25/22 | 10/11/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.18% | 261M | |
-30.67% | 9.05B | |
-9.60% | 2.66B | |
-24.06% | 1.18B | |
-9.21% | 222M | |
+19.33% | 138M |
- Stock Market
- Equities
- JLP Stock
- Financials Jubilee Metals Group Plc